Nerve Agent Antidote Kits

The Alabama Department of Public Health (ADPH) began providing nerve agent antidote kits to emergency medical services personnel several years ago. As funding allows, ADPH will continue to provide the devices to emergency medical service agencies that meet the required criteria. Agencies requesting nerve agent antidote kits must develop a program and train their staff on the program and antidote kits including indications, dosage, storage, etc. Training documentation and a request form must be submitted to ADPH.

 The nerve agent antidote kits currently provided are the DuodoteTM auto injectors which contain atropine 2.1 mg/0.7 mL and pralidoxime chloride 600 mg/2 mL.

DuodoteTM kits provided by ADPH are for responder self-use not patient use.

DuodoteTM kits distributed to Advanced Life Support (ALS) providers are assigned to the unit, not the individual.

DuodoteTM kits assigned to Basic Life Support (BLS) units are assigned to the individual (contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it for more information).

In case there is a need to re-dose, three kits will be provided per position.

DuodoteTM kits are distributed to ALS providers via their affiliate hospital pharmacy.

DuodoteTM kits should be maintained at room temperature (77 degrees Fahrenheit).
Brief departures between 59-86 degrees Fahrenheit are permissible.

Expired kits should be disposed of according to your organization's established policies and procedures. They are not to be returned to ADPH.

Agencies are responsible to ensure their employees are trained on the proper indications, use, procedures/protocols, etc.

When an agency makes the initial request for the nerve agent antidote kits, a skills check off sheet/training document with the trainer and medical director's signature must be provided to ADPH.